Literature DB >> 26699383

[Progression-free survival of patients with locally advanced NSCLC not improved by consolidation chemotherapy after concurrent chemoradiation].

Nadja Ebert1, Michael Baumann2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26699383     DOI： 10.1007/s00066-015-0933-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  15 in total

1.  Is consolidation chemotherapy after concurrent chemo-radiotherapy beneficial for patients with locally advanced non-small-cell lung cancer? A pooled analysis of the literature.

Authors:  Kazuyuki Tsujino; Takayasu Kurata; Satomi Yamamoto; Tomoya Kawaguchi; Akihito Kubo; Shunichi Isa; Yoshikazu Hasegawa; Sai-Hong Ignatius Ou; Minoru Takada; Masahiko Ando
Journal:  J Thorac Oncol       Date:  2013-09       Impact factor: 15.609

2.  Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Jean Bourhis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

3.  Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.

Authors:  Chandra P Belani; Hak Choy; Phil Bonomi; Charles Scott; Patrick Travis; John Haluschak; Walter J Curran
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

4.  Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.

Authors:  A Aupérin; C Le Péchoux; J P Pignon; C Koning; B Jeremic; G Clamon; L Einhorn; D Ball; M G Trovo; H J M Groen; J A Bonner; T Le Chevalier; R Arriagada
Journal:  Ann Oncol       Date:  2006-03       Impact factor: 32.976

5.  Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Authors:  Walter J Curran; Rebecca Paulus; Corey J Langer; Ritsuko Komaki; Jin S Lee; Stephen Hauser; Benjamin Movsas; Todd Wasserman; Seth A Rosenthal; Elizabeth Gore; Mitchell Machtay; William Sause; James D Cox
Journal:  J Natl Cancer Inst       Date:  2011-09-08       Impact factor: 13.506

6.  Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.

Authors:  Jin Seok Ahn; Yong Chan Ahn; Joo-Hang Kim; Chang Geol Lee; Eun Kyung Cho; Kyu Chan Lee; Ming Chen; Dong-Wan Kim; Hoon-Kyo Kim; Young Joo Min; Jin-Hyoung Kang; Jin-Hyuck Choi; Sang-We Kim; Guangying Zhu; Yi-Long Wu; Sung Rok Kim; Kyung Hee Lee; Hong Suk Song; Yoon-La Choi; Jong-Mu Sun; Sin-Ho Jung; Myung-Ju Ahn; Keunchil Park
Journal:  J Clin Oncol       Date:  2015-07-06       Impact factor: 44.544

7.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.

Authors:  R Arriagada; A Auperin; S Burdett; J P Higgins; D H Johnson; T Le Chevalier; C Le Pechoux; M K B Parmar; J P Pignon; R L Souhami; R J Stephens; L A Stewart; J F Tierney; H Tribodet; J van Meerbeeck
Journal:  Lancet       Date:  2010-03-24       Impact factor: 79.321

8.  Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.

Authors:  David R Gandara; Kari Chansky; Kathy S Albain; Bryan R Leigh; Laurie E Gaspar; Primo N Lara; Howard Burris; Paul Gumerlock; J Philip Kuebler; James D Bearden; John Crowley; Robert Livingston
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

9.  Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.

Authors:  Petr Zatloukal; Lubos Petruzelka; Milada Zemanova; Libor Havel; Filip Janku; Libor Judas; Antonin Kubik; Evzen Krepela; Pavel Fiala; Ladislav Pecen
Journal:  Lung Cancer       Date:  2004-10       Impact factor: 5.705

Review 10.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.